Ignite Creation Date:
2025-12-24 @ 5:00 PM
Ignite Modification Date:
2026-06-25 @ 7:07 AM
Study NCT ID:
NCT04523350
Status:
COMPLETED
Last Update Posted:
2024-12-16
First Post:
2020-08-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Instylla HES Hypervascular Tumor Pivotal Study
Sponsor:
Instylla, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hypervascular Tumors | View |
Keywords: